Hydroxyurea enhances sickle survival
- PMID: 20339102
- DOI: 10.1182/blood-2009-12-254979
Hydroxyurea enhances sickle survival
Comment on
-
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).Blood. 2010 Mar 25;115(12):2354-63. doi: 10.1182/blood-2009-05-221333. Epub 2009 Nov 10. Blood. 2010. PMID: 19903897 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources